- Oct 17, 2019
IM Therapeutics Raises $10 Million Financing Co-Led by JDRF T1D Fund and Morningside Ventures
IM Therapeutics is a clinical stage company developing personalized therapies for autoimmune disease. On October 9th, they announced that...
- Oct 16, 2019
Welcome IM Therapeutics to the C2I Family!
We would love to extend our warm welcome to IM Therapeutics! IM Therapeutics is redefining autoimmunity and transforming lives by...
- Aug 29, 2019
C2I Accelerator has incubated over 26 portfolio companies!
At C2I Accelerator, we have successfully incubated over 26 portfolio companies including companies like SQZ Biotech, Frequency...